HIV/AIDS Nutritional Support Protocol

Immune HealthModerate Evidence
7
supplements
2
Primary
5
Supporting
1
Grade A
76
Studies

Primary Stack

Core supplements with strongest evidence
High-potency multivitamin daily

Addresses common micronutrient deficiencies in HIV; may slow disease progression and reduce mortality

15 studies5,000 participants
200mcg daily

Deficiency common in HIV and associated with disease progression; supplementation may support immune function

10 studies800 participants

Supporting Stack

Additional supplements for enhanced results
2000-4000 IU daily (based on blood levels)

Deficiency extremely common in HIV; affects immune function and bone health

15 studies2,000 participants
15-45mg daily

Supports immune function; deficiency associated with faster HIV progression

8 studies600 participants
600-1800mg daily

Replenishes glutathione, which is depleted in HIV; supports immune cell function

8 studies400 participants
2-4g EPA+DHA daily

Anti-inflammatory effects; may help with lipid abnormalities from antiretroviral therapy

C-Reactive Protein (CRP)Cell Adhesion FactorsHigh-density lipoprotein (HDL)Low-density lipoprotein (LDL)Total cholesterol
10 studies600 participants
Multi-strain formula, 10-50 billion CFU daily

May support gut immune function and reduce microbial translocation

10 studies500 participants

How This Protocol Works

Simple Explanation

HIV (Human Immunodeficiency Virus) attacks the immune system, specifically CD4+ T cells. While antiretroviral therapy (ART) has transformed HIV into a manageable chronic condition, people living with HIV often have higher nutritional needs and are more susceptible to deficiencies. Proper nutrition supports immune function, helps maintain muscle mass, and can improve quality of life and potentially outcomes.

CRITICAL: This protocol is for nutritional support alongside antiretroviral therapy, NOT as a replacement for ART. ART is the cornerstone of HIV treatment. Always discuss supplements with your HIV care provider as some can interact with medications.

Multivitamin/Multimineral supplementation addresses the common micronutrient deficiencies in HIV. Large trials have shown that multivitamins can slow disease progression and reduce mortality, particularly in resource-limited settings. Even with ART, HIV increases metabolic demands and may impair nutrient absorption.
Selenium deficiency is very common in HIV and is associated with faster disease progression and higher mortality. Selenium is essential for antioxidant enzymes and immune cell function. Supplementation has been shown to suppress viral load and improve CD4 counts in some studies.
Vitamin D deficiency is extremely prevalent in people with HIV—up to 70-80% may be deficient. HIV itself, darker skin pigmentation, and some antiretroviral drugs contribute to deficiency. Vitamin D affects immune function and is crucial for bone health (important given increased osteoporosis risk in HIV).
Zinc supports multiple aspects of immune function. Deficiency accelerates HIV progression. Supplementation may help maintain CD4 counts and reduce opportunistic infections.
N-Acetylcysteine (NAC) replenishes glutathione, the body's master antioxidant. HIV dramatically depletes glutathione in immune cells, impairing their function. NAC supplementation can restore glutathione levels and may improve T cell function.
Omega-3 Fatty Acids have anti-inflammatory effects and can help manage the dyslipidemia (high triglycerides, abnormal cholesterol) that is common both from HIV infection and from some antiretroviral medications.
Probiotics may help restore the gut microbiome, which is significantly disrupted in HIV. Gut damage in HIV leads to bacterial translocation and chronic inflammation. Probiotics may help support the gut barrier and immune function.

Expected timeline: Effects are supportive and ongoing. Deficiency correction: 4-12 weeks. Always coordinate with your HIV care team.

Clinical Perspective

HIV infection causes chronic immune activation, inflammation, and metabolic disturbances. ART has transformed HIV into a manageable chronic disease, but people living with HIV (PLWH) have increased nutritional needs and risk of deficiencies. Malabsorption, increased metabolic demands, drug-nutrient interactions, and chronic inflammation contribute. This protocol addresses common deficiencies and supports immune and metabolic health.

CRITICAL: ART is the foundation of HIV treatment. Supplements are ADJUNCTIVE. Check for drug interactions—St. John's Wort is contraindicated with many ARVs. High-dose antioxidants have theoretical concerns (outdated). Discuss all supplements with HIV provider.

Multivitamin/Multimineral (A-grade): Addresses multiple deficiencies common in HIV (B vitamins, vitamin D, zinc, selenium). Landmark RCT: high-dose multivitamins (without vitamin A) reduced HIV progression and mortality in Tanzania (PMID: 15564907). Systematic review supports benefit (PMID: 22205419). High-potency formula without excessive vitamin A.
Selenium (B-grade): Deficiency in 40-70% of PLWH; correlates with disease progression. Selenium required for glutathione peroxidase (antioxidant), affects T cell proliferation and cytokine production. RCT: 200mcg/day suppressed viral load, slowed CD4 decline (PMID: 17585029). 200mcg daily; do not exceed 400mcg.
Vitamin D (B-grade): Deficiency in 60-80% of PLWH. Risk factors: HIV itself, dark skin, some ARVs (efavirenz, tenofovir). Affects innate immunity (cathelicidin), T cell function, bone health. Systematic review supports supplementation to correct deficiency (PMID: 26039619). Target 25(OH)D >40 ng/mL; 2000-4000 IU daily.
Zinc (B-grade): Essential for thymulin activity, T cell function, mucosal immunity. Deficiency accelerates HIV progression. RCT: zinc supplementation reduced opportunistic infections and diarrhea (PMID: 20861174). 15-45mg daily; do not exceed 40mg long-term without monitoring copper.
N-Acetylcysteine (NAC) (B-grade): Cysteine prodrug for glutathione synthesis. HIV depletes intracellular glutathione by 50-70%. Clinical study: NAC improved T cell glutathione and function (PMID: 9127512). Theoretical concern about antioxidants enhancing HIV replication not supported by clinical data. 600-1800mg daily.
Omega-3 Fatty Acids (B-grade): Reduce inflammation (elevated IL-6, TNF-α in HIV) and address dyslipidemia (common with HIV and PI/NNRTI-based regimens). Meta-analysis: EPA/DHA significantly reduce triglycerides in PLWH (PMID: 24768682). Also neuroprotective (HIV-associated neurocognitive disorders). 2-4g EPA+DHA daily.
Probiotics (C-grade): HIV causes profound gut damage (CD4 depletion in GALT), microbial translocation, and dysbiosis. Systematic review: probiotics may improve gut function and reduce inflammatory markers; mixed effects on CD4 (PMID: 25701092). Multi-strain formulas; strain-specific effects. Avoid in severely immunocompromised.

Biomarker targets: CD4 count, viral load (should be undetectable on ART), 25(OH)D, selenium, zinc, lipid panel, inflammatory markers (hsCRP, IL-6 if available), nutritional assessment.

Protocol notes: ART adherence is paramount—undetectable viral load eliminates transmission (U=U). Nutrition counseling for adequate protein (1.2-1.5 g/kg) and calories. Address food insecurity. Screen for hepatitis B/C coinfection. Cardiovascular risk management (increased CVD risk in HIV). Bone health monitoring (DXA if risk factors). Cancer screening per guidelines. Mental health support. Avoid St. John's Wort, garlic supplements in high doses (ARV interactions). Moderate alcohol; avoid hepatotoxins. Exercise for body composition and metabolic health. Vaccination per guidelines.